Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 May 15.
Published in final edited form as: Bioconjug Chem. 2019 Apr 10;30(5):1304–1308. doi: 10.1021/acs.bioconjchem.9b00188

Multistep Synthesis of 1,2,4-Oxadiazoles via DNA-Conjugated Aryl Nitrile Substrates

Huang-Chi Du 1,*, Madison C Bangs 1, Nicholas Simmons 1, Martin M Matzuk 1
PMCID: PMC6786255  NIHMSID: NIHMS1052636  PMID: 30964278

Abstract

A multistep protocol for the synthesis of 3,5-disubstituted 1,2,4-oxadiazoles on DNA-chemical conjugates has been developed. A set of six DNA-connected aryl nitriles were converted to corresponding amidoximes with hydroxylamine followed by the O-acylation with a series of aryl and aliphatic carboxylic acids. After cyclodehydration of the O-acyl amidoximes by heating at 90 °C in pH 9.5 borate buffer for two hours, the desired oxadiazole products were observed in 51─92% conversion with the cleavage of O-acylamidoximes as the major side-product. The reported protocol paves the way for the synthesis of oxadiazole core-focused DNA-encoded chemical libraries.

Graphical Abstracr

graphic file with name nihms-1052636-f0001.jpg

INTRODUCTION

DNA-encoded chemical libraries (DECLs) are collections of small molecules covalently linked to a unique, structure-identifying DNA tag which enables screens of large pools of library members for binders to biological targets.17 DECLs constructed by a split-and-pool8 strategy (i.e., iterative rounds of molecule functionalization, DNA-tag ligation and pooling) may routinely contain millions of encoded small molecule structures, and if used with post-screen high-throughput DNA sequencing,911 can interrogate enormous amounts of chemical space.12 However the success of DECL screening campaigns is influenced by the inherent diversity and fidelity of small molecule structures available within the DECL collection13,14 and many common synthetic transformations have not yet been demonstrated in solution-phase DECL production.15,16 This is due in part to stability and solubility limitations imposed by the presence of DNA within partially aqueous medium,13,14 and thus adaptation of synthetic transformations to DECL-friendly conditions is needed to further enhance the diversity of future DECL productions.

Oxadiazoles represent a privileged class of heterocycles that are frequently featured in discovery screening collections,17,18 are present in several approved pharmaceutical drugs,19,20 and have robust solution- and solid-phase synthetic methods.2131 In particular, the on-DNA formation of 1,2,4-oxadiazoles is an attractive DECL combinatorial methodology as 1,2,4-oxadiazoles may be constructed from nitriles and carboxylic acids, compound building block sets that have wide commercial-availability and diversity.32 A typical route to 1,2,4-oxadiazoles is through a three step process in which a nitrile 1 is converted to amidoxime 2 with hydroxylamine, coupled with a carboxylic acid to form O-acylamidoxime 3, and cyclodehydrated to the 1,2,4-oxadizole 4 (Figure 1).

Figure 1.

Figure 1.

General synthetic route of 1,2,4-oxadiazoles in conventional chemistry.

RESULTS AND DISCUSSION

To the best of our knowledge, this transformation has not been demonstrated on DNA-chemical conjugates aimed towards use in a DECL production. This may be partly due to presumed difficulties associated with the ultimate dehydration step in aqueous medium, as well as potential competing hydrolysis of synthetic sequence intermediates.33,34 To address these concerns, we initiated studies on the formation of 1,2,4-oxadiazoles from six DNA-attached aryl nitriles 1a1f connected to a DNA construct through common functional handle transformations. We chose to utilize a DNA-connected nitrile rather than carboxylic acid to enable direct observation of all steps on a DNA-conjugate, to avoid the need to pre-form amidoximes, and to allow use of general carboxylic acid stocks as this is a common building block for many DECL designs.32 Nitriles may be converted to amidoximes through attack of hydroxylamine under basic conditions35 and a survey of basic buffers (e.g. borate, phosphate) and bases (e.g., Na2CO3, NaOAc, Cs2CO3, NaOH, N,N-Diisopropylethylamine, triethylamine) generally showed comparable conversions of nitriles 1 to the amidoxime 2, albeit with prolonged reactions times (see Supporting Information for full details). Although heating could shorten the required reaction time, this led to mild decomposition of the DNA-chemical conjugates through formation of hydroxylamine DNA adducts and was avoided.36 Ultimately, use of pH 8.2 borate buffer with addition of a small amount of Na2CO3 cleanly provided the amidoximes 2a2f in excellent yield (Scheme 1).

Scheme 1.

Scheme 1.

Amidoxime formation from DNA-conjugated nitriles.

aConversions determined by LC-MS.

With the on-DNA amidoximes in hand, we next sought to find conditions that enabled the formation of the O-acylamidoximes 3, using amidoxime 2b and benzoic acid as a model system. Unfortunately, use of water-soluble DMTMM, a common coupling agent in DECL synthesis,37 resulted in negligible formation of the O-acylamidoxime 3b1. In other DECL studies, we have found DEPBT cleanly provides amidation products if the carboxylic acid is preactivated with coupling agent and Hunig’s base in acetonitrile.38 Application of this preactivation condition to 2b in several different buffers all provided 3b1 in modest yield. Previously EDC/HOAt has been described as an efficient reagent system for this transformation39 and applying this reagent combination provided 3b1 in 72–75% conversion (Table 1, entries 5–7). Switching to HATU under preactivation conditions further enhanced the conversion to 85–93% (Table 1, entries 8–10) but ultimately use of PyAOP without preactivation proved superior, providing 3b1 in excellent yield with pH 8.0 buffer and a slightly lessened yield with pH 9.5 buffer (Table 1, entries 11–12).

Table 1.

Optimization of o-acylation of amidoxime 2b.

graphic file with name nihms-1052636-t0002.jpg
entry buffer coupling reagent 3b1a (%)
1 pH 8.0 phosphate DMTMMb < 5%
2c pH 8.0 phosphate DEPBTd 61%
3c pH 8.2 borate DEPBT 54%
4c pH 9.5 borate DEPBT 63%
5c pH 8.0 phosphate EDCe/HOAtf 75%
6c pH 8.2 borate EDC/HOAt 72%
7c pH 9.5 borate EDC/HOAt 74%
8c pH 8.0 phosphate H HATUg 85%
9c pH 8.2 borate HATU 90%
10c pH 9.5 borate HATU 93%
11 pH 8.0 phosphate PyAOPh 95%
12 pH 9.5 borate PyAOP 85%
a

Conversions determined by LC-MS.

b

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride.

c

Carboxylic acid was preactivated by mixing with DIPEA (200 equiv) and coupling agent (200 equiv) in CH3CN for 15 min at 25 °C prior to use.

d

3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one.

e

1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide.

f

1-Hydroxy-7-azabenzotri-azole.

g

1-[Bis-(di-methylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium-3-oxid hexafluorophosphate.

h

(7-Azaben-zotriazol-1-yloxy) tripyrrolidinophophonium hexafluorophosphate.

Using the optimal PyAOP/pH 8.0 condition (Table 1, entry 11), we investigated the O-acylation of amidoximes 2a2f with a range of aryl and aliphatic carboxylic acids (Table 2). Gratifyingly, nearly all of the O-acylamidoximes were formed in very good to excellent conversion, with only slightly decreased conversions observed with electron-deficient amidoxime nucleophiles 2d2f. Notably, both aryl and aliphatic carboxylic acids could be coupled, including electron deficient pyridyl carboxylic acids and sterically-encumbered secondary and tertiary aliphatic carboxylic acids (Table 2). With this collection of O-acylamidoximes, we next turned towards optimizing the final cyclodehydration step of amidoxime formation on the model substrate 3b1. Typically, this cyclodehydration has been performed under basic, anhydrous, aprotic conditions at prolonged elevated temperature.26 Although stable under ambient conditions,40 heating O-acylamidoximes 3 in basic buffers may induce hydrolytic cleavage or elimination to ultimately provide a mixture of unreacted acylamidoxime 3, desired oxadiazole 4, amidoxime 2, and cyanide 1.

Table 2.

Substrate scope of o-acylation with carboxylic acids.a

graphic file with name nihms-1052636-t0003.jpg
2a 2b 2c 2d 2e 2f
1graphic file with name nihms-1052636-t0004.jpg 3a1: 94% 3b1: 95% 3c1: 95% 3d1: 92% 3e1: 99% 3f1: 92%
2graphic file with name nihms-1052636-t0005.jpg 3a2: 97% 3b2: 98% 3c2: 95% 3d2: 92% 3e2: 99% 3f2: 90%
3graphic file with name nihms-1052636-t0006.jpg 3a3: 94% 3b3: 95% 3c3: 94% 3d3: 92% 3e3: 98% 3f3: 96%
4graphic file with name nihms-1052636-t0007.jpg 3a4: 89% 3b4: 96% 3c4: 94% 3d4: 90% 3e4: 96% 3f4: 88%
5graphic file with name nihms-1052636-t0008.jpg 3a5: 91% 3b5: 97% 3c5: 95% 3d5: 84% 3e5: 97% 3f5: 81%
6graphic file with name nihms-1052636-t0009.jpg 3a6: 90% 3b6: 99% 3c6: 94% 3d6: 89% 3e6: 98% 3f6: 87%
7graphic file with name nihms-1052636-t0010.jpg 3a7: 81% 3b7: 90% 3c7: 94% 3d7: 88% 3e7: 90% 3f7: 73%
8graphic file with name nihms-1052636-t0011.jpg 3a8: 97% 3b8: 97% 3c8: 96% 3d8: 94% 3e8: 99% 3f8: 91%
9graphic file with name nihms-1052636-t0012.jpg 3a9: 97% 3b9: 99% 3c9: 94% 3d9: 93% 3e9: 98% 3f9: 93%
a

Conversions determined by LC-MS.

Our initial tests concentrated on the use of pH 9.5 borate buffer at elevated temperatures, as we have found this to be an optimal basic buffer system that maintains DNA and amide bond integrity for other reactions which require prolonged heating.41 Use of this buffer alone or with a variety of additives produced the desired oxadiazole in fair yields, although with significant amounts of hydrolysis product 2b (Table 3, entries 1–6). Lowering the starting pH of the buffer system suppressed hydrolysis to 2b but led to large amounts of unreacted 3b even after 16 h (Table 3, entries 7–8). Increasing the temperature to 80 °C in pH 9.5 borate buffer with N,N-diisopropylethylamine as an additive42 boosted formation of 4b to 83% after only 1.5 h, and ultimately application of the same system at 90 °C resulted in slightly improved conversion to the desired oxadiazole (Table 3, entries 9–10). Encouraged by this result, we applied this cyclodehydration condition to our collection of O-acylamidoximes 3a13f9 which produced all oxadiazoles 4a14f9 in fair to very good yields (Table 4). Although lowered conversion and significant hydrolysis was observed for all electron-deficient pyridyl substrates 3d1–3d9, overall a variety of electronically-diverse aryl and alkyl substituted oxadiazoles were prepared through this multistep protocol.

Table 3.

Optimization of cyclodehydration of acylamidoximes conditions.

graphic file with name nihms-1052636-t0013.jpg
entry buffera baseb temperature time 4b1c (%) 2bc (%) 3b1c (%) 1bc (%)
1 pH 9.5 borate None 60 °C 16 h 54% 28% 9% Trace
2 pH 9.5 borate NaOAcd 60 °C 16 h 53% 26% 10% Trace
3 pH 9.5 borate Cs2CO3e 60 °C 16 h 59% 24% 9% Trace
4 pH 9.5 borate NaHCO3f 60 °C 16 h 54% 25% 10% Trace
5 pH 9.5 borate Et3Ng 60 °C 16 h 57% 23% 20% Trace
6 pH 9.5 borate DIPEAh 60 °C 16 h 60% 27% 13% Trace
7 pH 8.2 borate DIPEA 60 °C 16 h 52% 11% 37% Trace
8 pH 8.0 phosphate H DIPEA 60 °C 16 h 53% 8% 39% Trace
9 pH 9.5 borate DIPEA 80 °C 1.5 h 83% 17% Trace Trace
10 pH 9.5 borate DIPEA 90 °C 1.5 h 86% 14% Trace Trace
a

500 equiv used.

b

100 equiv used.

c

Conversions determined by LC-MS.

d

Sodium acetate.

e

Cesium carbonate.

f

Sodium bicarbonate.

g

Triethylamine.

h

N,N-diisopropylethylamine.

Table 4.

The synthesis of 1,2,4-oxadiazoles via cyclodehydration of acylamidoximes.a,b

graphic file with name nihms-1052636-t0014.jpg
R1= graphic file with name nihms-1052636-t0015.jpg graphic file with name nihms-1052636-t0016.jpg graphic file with name nihms-1052636-t0017.jpg graphic file with name nihms-1052636-t0018.jpg graphic file with name nihms-1052636-t0019.jpg graphic file with name nihms-1052636-t0020.jpg graphic file with name nihms-1052636-t0021.jpg graphic file with name nihms-1052636-t0022.jpg graphic file with name nihms-1052636-t0023.jpg
Products
graphic file with name nihms-1052636-t0024.jpg 4a1: 79% 4a2: 69% 4a3: 69% 4a4: 66% 4a5: 82% 4a6: 69% 4a7: 78% 4a8: 79% 4a9: 65%
graphic file with name nihms-1052636-t0025.jpg 4b1: 82% 4b2: 78% 4b3: 77% 4b4: 74% 4b5: 82% 4b6: 71% 4b7: 75% 4b8: 87% 4b9: 69%
graphic file with name nihms-1052636-t0026.jpg 4c1: 89% 4c2: 86% 4c3: 81% 4c4: 83% 4c5: 92% 4c6: 81% 4c7: 70% 4c8: 88% 4c9: 79%
graphic file with name nihms-1052636-t0027.jpg 4d1: 68% 4d2: 62% 4d3: 60% 4d4: 63% 4d5: 67% 4d6: 56% 4d7: 53% 4d8: 61% 4d9: 51%
graphic file with name nihms-1052636-t0028.jpg 4e1: 81% 4e2: 77% 4e3: 76% 4e4: 77% 4e5: 85% 4e6: 74% 4e7: 75% 4e8: 78% 4e9: 71%
graphic file with name nihms-1052636-t0029.jpg 4f1: 86% 4f2: 84% 4f3: 80% 4f4: 85% 4f5: 92% 4f6: 80% 4f7: 81% 4f8: 87% 4f9: 72%
a

Conversions determined by LC-MS.

b

Trace amount to 10% of cyanides 1a1f were also observed.

Finally to further corroborate the formation of the DNA-conjugated oxadiazole product, we sought to compare the synthesis of amide-bound 1,2,4-oxadizole ataluren derivative 6b prepared through our four-step process with the ataluren derivative 6a prepared through direct acylation of commercially-obtained ataluren (Scheme 2). Formation of 6a and 6b proceeded smoothly through both synthetic routes and both were found to have identical retention on LC-MS during co-injection studies. To simulate the late-stage use of this process in a DECL production, these studies were performed on elongated DNA 5 (56 b.p.). No DNA degradation was detected and post-reaction 6b efficiently ligated with a duplexed pair of 12 b.p. DNA oligomers (see Supporting Information for full details).

Scheme 2.

Scheme 2.

(a) Synthesis of DNA-conjugate 6a via acylation with ataluren. (b) Multistep synthesis of 1,2,4-oxadiazole 6b and enzymatic ligation.

CONCLUSIONS

In summary, we have demonstrated an efficient multistep synthesis of diverse 3,5-disubstituted 1,2,4-oxadiazoles on DNA-chemical conjugates. DNA-conjugated aryl nitriles were converted to 1,2,4-oxadiazoles through a four step process featuring conversion to the amidoxime, amidoxime O-acylation with a variety of aryl and aliphatic carboxylic acids, and cyclodehydration of O-acylamidoxime intermediates. This protocol produced a variety of electronically- and sterically-substituted oxadiazoles, utilizes building blocks that are widely commercially-available, and preserves the integrity of DNA. Efforts to apply this method within a full-scale DECL synthesis are ongoing and will be reported in due course.

Supplementary Material

Supplemental Files

ACKNOWLEDGMENT

This work was supported by the Welch Foundation (Grant Q-0042), a Core Facility Support Award (RP160805) from the Cancer Prevention Research Institute of Texas (CPRIT), and National Institutes of Health grant P01HD087157 from The Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Footnotes

The authors declare no competing financial interest.

Supporting Information

The Supporting Information is available free of charge on the ACS Publications website.

Details of experimental procedures and DNA structures.

REFERENCES

  • 1.Favalli N; Bassi G; Scheuermann J; Neri D, DNA-encoded chemical libraries - achievements and remaining challenges. FEBS letters 2018, 592 (12), 2168–2180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lerner RA; Brenner S, DNA-Encoded Compound Libraries as Open Source: A Powerful Pathway to New Drugs. Angewandte Chemie International Edition 2017, 56 (5), 1164–1165. [DOI] [PubMed] [Google Scholar]
  • 3.Neri D, Twenty-five Years of DNA-Encoded Chemical Libraries. ChemBioChem 2017, 18 (9), 827–828. [DOI] [PubMed] [Google Scholar]
  • 4.Franzini RM; Neri D; Scheuermann J, DNA-Encoded Chemical Libraries: Advancing beyond Conventional Small-Molecule Libraries. Accounts of Chemical Research 2014, 47 (4), 1247–1255. [DOI] [PubMed] [Google Scholar]
  • 5.Goodnow RA Jr; Dumelin CE; Keefe AD, DNA-encoded chemistry: enabling the deeper sampling of chemical space. Nature Reviews Drug Discovery 2016, 16, 131. [DOI] [PubMed] [Google Scholar]
  • 6.Neri D; Lerner RA, DNA-Encoded Chemical Libraries: A Selection System Based on Endowing Organic Compounds with Amplifiable Information. Annual Review of Biochemistry 2018, 87 (1), 479–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kleiner RE; Dumelin CE; Liu DR, Small-molecule discovery from DNA-encoded chemical libraries. Chemical Society Reviews 2011, 40 (12), 5707–5717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.R Halpin D; B Harbury P, DNA Display II. Genetic Manipulation of Combinatorial Chemistry Libraries for Small-Molecule Evolution. 2004; Vol. 2, p E174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Arico-Muendel CC, From haystack to needle: finding value with DNA encoded library technology at GSK. MedChemComm 2016, 7 (10), 1898–1909. [Google Scholar]
  • 10.Shi B; Zhou Y; Huang Y; Zhang J; Li X, Recent advances on the encoding and selection methods of DNA-encoded chemical library. Bioorg Med Chem Lett 2017, 27 (3), 361–369. [DOI] [PubMed] [Google Scholar]
  • 11.Kircher M; Sawyer S; Meyer M, Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform. Nucleic Acids Research 2011, 40 (1), e3–e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Franzini RM; Randolph C, Chemical Space of DNA-Encoded Libraries. Journal of Medicinal Chemistry 2016, 59 (14), 6629–6644. [DOI] [PubMed] [Google Scholar]
  • 13.Satz AL; Cai J; Chen Y; Goodnow R; Gruber F; Kowalczyk A; Petersen A; Naderi-Oboodi G; Orzechowski L; Strebel Q, DNA Compatible Multistep Synthesis and Applications to DNA Encoded Libraries. Bioconjugate Chemistry 2015, 26 (8), 1623–1632. [DOI] [PubMed] [Google Scholar]
  • 14.Malone ML; Paegel BM, What is a “DNA-Compatible” Reaction? ACS Combinatorial Science 2016, 18 (4), 182–187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Halpin DR; Lee JA; Wrenn SJ; Harbury PB, DNA Display III. Solid-Phase Organic Synthesis on Unprotected DNA. PLOS Biology 2004, 2 (7), e175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.MacConnell AB; McEnaney PJ; Cavett VJ; Paegel BM, DNA-Encoded Solid-Phase Synthesis: Encoding Language Design and Complex Oligomer Library Synthesis. ACS Combinatorial Science 2015, 17 (9), 518–534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Boström J; Hogner A; Llinàs A; Wellner E; Plowright AT, Oxadiazoles in Medicinal Chemistry. Journal of Medicinal Chemistry 2012, 55 (5), 1817–1830. [DOI] [PubMed] [Google Scholar]
  • 18.Ozcan S; Kazi A; Marsilio F; Fang B; Guida WC; Koomen J; Lawrence HR; Sebti SM, Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome Inhibitors. Journal of Medicinal Chemistry 2013, 56 (10), 3783–3805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bento AP; Gaulton A; Hersey A; Al-Lazikani B; Michalovich D; Chambers J; Bellis LJ; Davies M; McGlinchey S; Light Y; Overington JP, ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Research 2011, 40 (D1), D1100–D1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Maciejewski A; Tang A; Guo AC; Han B; Ly C; Knox C; Arndt D; Gabriel G; Wilson M; Adamjee S; Jewison T; Neveu V; Law V; Djoumbou Y; Liu Y; Zhou Y; Dame ZT; Wishart DS, DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Research 2013, 42 (D1), D1091–D1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.De Oliveira CS; Lira BF; Barbosa-Filho JM; Lorenzo JGF; De Athayde-Filho PF, Synthetic Approaches and Pharmacological Activity of 1,3,4-Oxadiazoles: A Review of the Literature from 2000–2012. Molecules 2012, 17 (9). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Khalilullah H; Ahsan MJ; Md H; Khan S; Ahmed B, 1,3,4-Oxadiazole: A Biologically Active Scaffold. Mini-Reviews in Medicinal Chemistry 2012, 12 (8), 789–801. [DOI] [PubMed] [Google Scholar]
  • 23.Rajesh OB; Bashir D; Vidya P; Mazahar F, [1, 2, 4]-Oxadiazoles: Synthesis and Biological Applications. Mini-Reviews in Medicinal Chemistry 2014, 14 (4), 355–369. [DOI] [PubMed] [Google Scholar]
  • 24.Ziga J; Marija Sollner D, Recent Advances in the Synthesis of 1,2,4- and 1,3,4-Oxadiazoles. Current Organic Chemistry 2008, 12 (10), 850–898. [Google Scholar]
  • 25.Paolo Q; Pierluigi C, Synthesis and Synthetic Applications of 1,2,4-Oxadiazole-4-Oxides. Current Organic Chemistry 2007, 11 (11), 959–986. [Google Scholar]
  • 26.Kayukova LA, Synthesis of 1,2,4-oxadiazoles (a review). Pharmaceutical Chemistry Journal 2005, 39 (10), 539–547. [Google Scholar]
  • 27.Abdildinova A; Gong Y-D, Current Parallel Solid-Phase Synthesis of Drug-like Oxadiazole and Thiadiazole Derivatives for Combinatorial Chemistry. ACS Combinatorial Science 2018, 20 (6), 309–329. [DOI] [PubMed] [Google Scholar]
  • 28.Augustine JK; Akabote V; Hegde SG; Alagarsamy P, PTSA−ZnCl2: An Efficient Catalyst for the Synthesis of 1,2,4-Oxadiazoles from Amidoximes and Organic Nitriles. The Journal of Organic Chemistry 2009, 74 (15), 5640–5643. [DOI] [PubMed] [Google Scholar]
  • 29.Tolmachev A; Bogolubsky AV; Pipko SE; Grishchenko AV; Ushakov DV; Zhemera AV; Viniychuk OO; Konovets AI; Zaporozhets OA; Mykhailiuk PK; Moroz YS, Expanding Synthesizable Space of Disubstituted 1,2,4-Oxadiazoles. ACS Combinatorial Science 2016, 18 (10), 616–624. [DOI] [PubMed] [Google Scholar]
  • 30.Baykov S; Sharonova T; Shetnev A; Rozhkov S; Kalinin S; Smirnov AV, The first one-pot ambient-temperature synthesis of 1,2,4-oxadiazoles from amidoximes and carboxylic acid esters. Tetrahedron 2017, 73 (7), 945–951. [Google Scholar]
  • 31.Sharonova T; Pankrat’eva V; Savko P; Baykov S; Shetnev A, Facile room-temperature assembly of the 1,2,4-oxadiazole core from readily available amidoximes and carboxylic acids. Tetrahedron Letters 2018, 59 (29), 2824–2827. [Google Scholar]
  • 32.Satz AL, Foundations of a DNA-Encoded Library (DEL) In A Handbook for DNA‐Encoded Chemistry, Goodnow RA (Ed.). 2014. [Google Scholar]
  • 33.Kočevar M; Stanovnik B; Tišler M, Syntheses and transformations of some 1,2,4-oxadiazolylpyrazines. Journal of Heterocyclic Chemistry 1982, 19 (6), 1397–1402. [Google Scholar]
  • 34.Faisal M; Sato N; Quitain AT; Daimon H; Fujie K, Hydrolysis and Cyclodehydration of Dipeptide under Hydrothermal Conditions. Industrial & Engineering Chemistry Research 2005, 44 (15), 5472–5477. [Google Scholar]
  • 35.Judkins BD; Allen DG; Cook TA; Evans B; Sardharwala TE, A Versatile Synthesis of Amidines from Nitriles Via Amidoximes. Synthetic Communications 1996, 26 (23), 4351–4367. [Google Scholar]
  • 36.Hydroxylamine can induce downstream mutagenic PCR effects generally through substitution of DNA base amino groups with hydroxylamine. However under our optimized conditions these covalent adducts were not significant detected by LC-MS (< 5%)
  • 37.Valeur E; Bradley M, Amide bond formation: beyond the myth of coupling reagents. Chemical Society Reviews 2009, 38 (2), 606–631. [DOI] [PubMed] [Google Scholar]
  • 38.Du H-C; Simmons N; Faver J; Yu Z; Palaniappan M; Riehle K; Matzuk M, A mild, DNA-compatible nitro reduction using B2(OH)4. Organic Letter ASAP DOI: 10.1021/acs.orglett.9b00497 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Li Y; Gabriele E; Samain F; Favalli N; Sladojevich F; Scheuermann J; Neri D, Optimized Reaction Conditions for Amide Bond Formation in DNA-Encoded Combinatorial Libraries. ACS Combinatorial Science 2016, 18 (8), 438–443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Samples of O-acyl amidoximes left at room temperature in neutral water for one week were found to be fully intact by LC-MS.
  • 41.Luk KC; Satz AL, DNA-Compatible Chemistry In A Handbook for DNA‐Encoded Chemistry, Goodnow RA (Ed.). 2014. [Google Scholar]
  • 42.The reactions appeared to have comparable conversions with or without the addition of DIPEA. However, the LC-MS trace seemed to be slightly cleaner in the presence of DIPEA.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Files

RESOURCES